Science Explorer Interactive view Map

UCB Pharma (Germany)

In research, UCB Pharma (Germany) stands highest in Medicine (#10,480 of 17,978 worldwide) and Health Sciences (#12,622 of 20,462 worldwide), over all time.

World rank, all time
#21,936
of 42,892
Rank in Germany
#1,041
of 2,077
Research works
308
▼ 16% vs 2013–17
Citations
8.2k
26.6 per fractional work
Top-10% rate
14.6%
record average 16.5%
Open access
28%
world 28%

What is UCB Pharma (Germany) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #10,480 of 17,978 17.6%191
Health SciencesDomain #12,622 of 20,462 17.4%201

Each strip is that field’s whole ranked pool, with the notch where UCB Pharma (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.84× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 8.08× its world share, 4 worksImmunology and Micro…Neuroscience: 1.44× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.68× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.81× its world share, 1 worksChemistryComputer Science: 0.16× its world share, 1 worksComputer ScienceEnergy: 0.98× its world share, 0 worksEnergyEngineering: 0.19× its world share, 2 worksEngineeringEnvironmental Science: 0.10× its world share, 0 worksEnvironmental ScienceMathematics: 0.67× its world share, 0 worksMathematicsDentistry: 0.92× its world share, 0 worksDentistryHealth Professions: 0.79× its world share, 1 worksHealth ProfessionsMedicine: 2.66× its world share, 28 worksMedicineNursing: 0.24× its world share, 0 worksNursingVeterinary: 1.47× its world share, 0 worksVeterinaryArts and Humanities: 0.05× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 4.50× its world share, 8 worksBusiness, Management…Decision Sciences: 0.84× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.49× its world share, 2 worksEconomics, Econometr…Psychology: 0.43× its world share, 1 worksPsychologySocial Sciences: 0.18× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.1×. Every wedge is a field page.

Who are the top researchers at UCB Pharma (Germany)?

Ranked on the composite score, Joachim Freitag, Bengt Hoepken and Babak Boroojerdi lead among researchers whose main affiliation is UCB Pharma (Germany).

  1. 1 Joachim Freitag Germany · #406,523 worldwide 60 citations · 20 works
  2. 2 Bengt Hoepken Germany · #700,177 worldwide 21 citations · 17 works
  3. 3 Babak Boroojerdi Germany · #1,121,767 worldwide 23 citations · 32 works
  4. 4 T. Kumke Germany · #1,521,153 worldwide 5 citations · 20 works
All ranked researchers at UCB Pharma (Germany)

Which keywords describe research at UCB Pharma (Germany)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Digital Transformation, Leadership, Organizational Change, Autoantibodies, Inflammation, Management, Regulatory T Cells and Inflammatory Cytokines.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Digital Transformation8▲ 26×3 topics
  2. Inflammation6▲ 5.0×17 topics
  3. Leadership6▲ 21×2 topics
  4. Organizational Change6▲ 140×2 topics
  5. Autoantibodies5▲ 42×8 topics
  6. Epidemiology5▲ 2.2×18 topics
  7. Management4▲ 8.7×9 topics
  8. Regulatory T Cells4▲ 59×3 topics
  9. Immune System4▲ 28×2 topics
  10. Inflammatory Cytokines4▲ 81×2 topics
  11. TGF-ß4▲ 43×2 topics
  12. IL-174▲ 191×1 topic
  13. TH17 Cells4▲ 191×1 topic
  14. Antiepileptic Drugs3▲ 75×2 topics
  15. Agility3▲ 393×1 topic
  16. Prognosis3▲ 16×4 topics
  17. Quality of Life3▲ 3.8×8 topics
  18. Socio-Technical Systems3▲ 230×1 topic
  19. Sustainable Development3▲ 3.4×2 topics
  20. Ankylosing Spondylitis3▲ 184×1 topic
  21. Spondyloarthritis3▲ 184×1 topic
  22. Immunotherapy3▲ 7.1×7 topics
  23. Industrial Psychology3▲ 729×1 topic
  24. Strategic Innovation3▲ 1525×1 topic
  25. Epilepsy3▲ 44×3 topics
  26. Genetics3▲ 6.7×5 topics
  27. Neurological Disorders3▲ 8.3×8 topics
  28. Myasthenia Gravis2▲ 221×1 topic
  29. Thymic Tumors2▲ 221×1 topic
  30. Neurobiology2▲ 16×3 topics
  31. Classification2▲ 8.6×2 topics
  32. Surgery2▲ 11×2 topics
  33. Business Models2▲ 51×1 topic
  34. Customer Experience2▲ 24×1 topic
  35. Mobile Health2▲ 27×2 topics
  36. Rheumatoid Arthritis2▲ 38×2 topics
  37. Seizures2▲ 60×1 topic
  38. Status Epilepticus2▲ 79×1 topic
  39. Cytokines2▲ 11×3 topics
  40. Monoclonal Antibodies2▲ 35×3 topics

Which research topics does UCB Pharma (Germany) publish most on?

By volume in 2022–2025: Psoriasis: Treatment and Pathogenesis, Corporate Management and Leadership, Spondyloarthritis Studies and Treatments and Organizational Management and Change.

  1. 1 Psoriasis: Treatment and Pathogenesis Immunology 4 works
  2. 2 Corporate Management and Leadership Organizational Behavior and Human Resource Management 3 works
  3. 3 Spondyloarthritis Studies and Treatments Rheumatology 3 works
  4. 4 Organizational Management and Change Organizational Behavior and Human Resource Management 3 works
  5. 5 Myasthenia Gravis and Thymoma Neurology 2 works
  6. 6 Epilepsy research and treatment Psychiatry and Mental health 2 works
  7. 7 Digital Innovation in Industries Management of Technology and Innovation 2 works
  8. 8 Rheumatoid Arthritis Research and Therapies Rheumatology 2 works
  9. 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  10. 10 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.4%not open71.6%

World: 28% of research is openly available.

with international co-authors45.3%domestic only54.7%

World: 19% is written across borders.

How has UCB Pharma (Germany)'s research output changed?

Output in 2018–2022 was 16% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Monheim am Rhein

All research institutions in Monheim am Rhein

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.